Literature DB >> 17579530

Point-of-care testing, medical error, and patient safety: a 2007 assessment.

Sharon S Ehrmeyer1, Ronald H Laessig.   

Abstract

Point-of-care testing (POCT) is the fastest growing segment of a US$30 billion worldwide market. "Errors" in the testing process, as well as medical data interpretation and treatment associated with POCT, are recognized as leading to major compromises of patient safety. In today's environment, most testing errors (pre-analytical, analytical and post-analytical) can be virtually eliminated by proper design of testing systems. We cite examples of two systems that have made exceptional progress in this respect. It has been recently suggested that the basic errors associated with the testing process are amplified in the POC setting. Two of the amplifiers - incoherent regulations and failure of clinician/caregivers to respond appropriately to POCT results - lead us to recognize additional changes in today's POCT environment. The first is a willingness of manufacturers, not laboratories, to take responsibility for the quality of test results - an outgrowth of an industrial philosophy called autonomation. The second is a need to substantially modify the clinician/caregiver test utilization paradigm to take full advantage of POCT results, available on site in real time. Both have already begun to take place.

Entities:  

Mesh:

Year:  2007        PMID: 17579530     DOI: 10.1515/CCLM.2007.164

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  8 in total

Review 1.  Point-of-care nucleic acid testing for infectious diseases.

Authors:  Angelika Niemz; Tanya M Ferguson; David S Boyle
Journal:  Trends Biotechnol       Date:  2011-03-04       Impact factor: 19.536

2.  Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries.

Authors:  Nitika Pant Pai; Caroline Vadnais; Claudia Denkinger; Nora Engel; Madhukar Pai
Journal:  PLoS Med       Date:  2012-09-04       Impact factor: 11.069

Review 3.  Plan for quality to improve patient safety at the point of care.

Authors:  Sharon S Ehrmeyer
Journal:  Ann Saudi Med       Date:  2011 Jul-Aug       Impact factor: 1.526

Review 4.  Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic Technologies.

Authors:  Luc Bissonnette; Michel G Bergeron
Journal:  J Pers Med       Date:  2012-05-02

5.  Lab-on-a-Drone: Toward Pinpoint Deployment of Smartphone-Enabled Nucleic Acid-Based Diagnostics for Mobile Health Care.

Authors:  Aashish Priye; Season Wong; Yuanpeng Bi; Miguel Carpio; Jamison Chang; Mauricio Coen; Danielle Cope; Jacob Harris; James Johnson; Alexandra Keller; Richard Lim; Stanley Lu; Alex Millard; Adriano Pangelinan; Neal Patel; Luke Smith; Kamfai Chan; Victor M Ugaz
Journal:  Anal Chem       Date:  2016-04-21       Impact factor: 6.986

Review 6.  Glycosylated gold nanoparticles in point of care diagnostics: from aggregation to lateral flow.

Authors:  Alexander N Baker; George W Hawker-Bond; Panagiotis G Georgiou; Simone Dedola; Robert A Field; Matthew I Gibson
Journal:  Chem Soc Rev       Date:  2022-08-15       Impact factor: 60.615

7.  Results of a survey among GP practices on how they manage patient safety aspects related to point-of-care testing in every day practice.

Authors:  Claudette de Vries; Carine Doggen; Ellen Hilbers; Robert Verheij; Maarten IJzerman; Robert Geertsma; Ron Kusters
Journal:  BMC Fam Pract       Date:  2015-02-05       Impact factor: 2.497

8.  Method validation of a set of 12 GEM® Premier™ 4000 blood gas analyzers for point-of-care testing in a university teaching hospital.

Authors:  Charlotte Oris; Yoan Clavel; Matthieu Jabaudon; Annick Pialat; Hadj Abdelkader Mohamed; Frédérique Lioret; Vincent Sapin; Damien Bouvier
Journal:  Pract Lab Med       Date:  2017-12-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.